These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparative studies of Nsc and Fmoc as N(alpha)-protecting groups for SPPS. Ramage R; Jiang L; Kim YD; Shaw K; Park JL; Kim HJ J Pept Sci; 1999 Apr; 5(4):195-200. PubMed ID: 10323199 [TBL] [Abstract][Full Text] [Related]
25. Straightforward entry to S-glycosylated fmoc-amino acids and their application to solid phase synthesis of glycopeptides and glycopeptidomimetics. Comegna D; de Paola I; Saviano M; Del Gatto A; Zaccaro L Org Lett; 2015 Feb; 17(3):640-3. PubMed ID: 25622618 [TBL] [Abstract][Full Text] [Related]
26. Quaternary β Yu JS; Noda H; Shibasaki M Angew Chem Int Ed Engl; 2018 Jan; 57(3):818-822. PubMed ID: 29168280 [TBL] [Abstract][Full Text] [Related]
38. N-alkoxycarbonyl-glutamic and aspartic acids. Studies on the activation and cyclodehydration and side-reaction encountered in analysis of glutamic acid using Fmoc-chloride. Chen FM; Benoiton NL Int J Pept Protein Res; 1992 Jul; 40(1):13-8. PubMed ID: 1358849 [TBL] [Abstract][Full Text] [Related]
39. The aspartimide problem in Fmoc-based SPPS. Part II. Mergler M; Dick F; Sax B; Stähelin C; Vorherr T J Pept Sci; 2003 Aug; 9(8):518-26. PubMed ID: 12952393 [TBL] [Abstract][Full Text] [Related]
40. Amino acid building blocks for Fmoc solid-phase synthesis of peptides phosphocholinated at serine, threonine, and tyrosine. Albers MF; Hedberg C J Org Chem; 2013 Mar; 78(6):2715-9. PubMed ID: 23373758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]